IRWD
Price:
$4.51
Market Cap:
$720.42M
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary ch...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-03
Stock Exchange
NASDAQ
Ticker
IRWD
According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.26B. This represents a change of -37.54% compared to the average of 2.01B of the last 4 quarters.
The mean historical Enterprise Value of Ironwood Pharmaceuticals, Inc. over the last ten years is 2.09B. The current 1.26B Enterprise Value has changed 5.91% with respect to the historical average. Over the past ten years (40 quarters), IRWD's Enterprise Value was at its highest in in the June 2018 quarter at 3.17B. The Enterprise Value was at its lowest in in the March 2023 quarter at 1.30B.
Average
2.09B
Median
2.05B
Minimum
1.67B
Maximum
2.53B
Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 51.81%
Maximum Annual Enterprise Value = 2.53B
Minimum Annual Increase = -27.10%
Minimum Annual Enterprise Value = 1.67B
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.40B | 43.61% |
2022 | 1.67B | -4.30% |
2021 | 1.75B | -8.37% |
2020 | 1.91B | -18.18% |
2019 | 2.33B | 27.93% |
2018 | 1.82B | -27.10% |
2017 | 2.50B | -1.40% |
2016 | 2.53B | 43.39% |
2015 | 1.77B | -19.61% |
2014 | 2.20B | 51.81% |
The current Enterprise Value of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.94B
5-year avg
2.01B
10-year avg
2.09B
Ironwood Pharmaceuticals, Inc.’s Enterprise Value is less than Neurocrine Biosciences, Inc. (12.29B), less than Amphastar Pharmaceuticals, Inc. (2.64B), less than Collegium Pharmaceutical, Inc. (1.58B), less than ANI Pharmaceuticals, Inc. (1.34B), less than Alkermes plc (4.26B), less than Intra-Cellular Therapies, Inc. (7.09B), less than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Pacira BioSciences, Inc. (1.04B), less than Avadel Pharmaceuticals plc (1.40B), greater than Eagle Pharmaceuticals, Inc. (110.03M), greater than Assertio Holdings, Inc. (116.04M), greater than Esperion Therapeutics, Inc. (691.10M),
Company | Enterprise Value | Market cap |
---|---|---|
12.29B | $12.13B | |
2.64B | $2.21B | |
1.58B | $1.20B | |
1.34B | $1.27B | |
4.26B | $4.42B | |
7.09B | $7.77B | |
2.15B | $2.21B | |
1.04B | $638.86M | |
1.40B | $1.39B | |
110.03M | $55.19M | |
116.04M | $120.12M | |
691.10M | $323.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ironwood Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 3-year average Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 5-year average Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?
How does the current Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD) compare to its historical average?